These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 25129672)

  • 21. Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients.
    Bleiziffer S; Mazzitelli D; Opitz A; Hettich I; Ruge H; Piazza N; Lange R
    J Thorac Cardiovasc Surg; 2012 Feb; 143(2):310-7. PubMed ID: 22137802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early experience of implantation of the new CoreValve(®) Evolut(™) in degenerated bioprosthetic aortic valves.
    Fairley SL; Jeganathan R; Manoharan G; Spence MS
    Catheter Cardiovasc Interv; 2014 Feb; 83(3):485-92. PubMed ID: 23857751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DynaCT-guided anatomical rotation of the SAPIEN XT valve during transapical aortic valve implantation: proof of concept.
    Blumenstein JM; Van Linden A; Moellmann H; Seeburger J; Rastan A; Kim WK; Mohr FW; Kempfert J; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):409-13. PubMed ID: 23247690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation.
    Takagi K; Latib A; Al-Lamee R; Mussardo M; Montorfano M; Maisano F; Godino C; Chieffo A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2011 Sep; 78(3):432-43. PubMed ID: 21793168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aortic regurgitation after transcatheter aortic valve implantation of the Edwards SAPIEN ™ valve.
    Nielsen HH; Egeblad H; Andersen HR; Thuesen L; Poulsen SH; Klaaborg KE; Jakobsen CJ; Hjortdal VE
    Scand Cardiovasc J Suppl; 2013 Feb; 47(1):36-41. PubMed ID: 22989057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency and prophylactic use of miniaturized veno-arterial extracorporeal membrane oxygenation in transcatheter aortic valve implantation.
    Husser O; Holzamer A; Philipp A; Nunez J; Bodi V; Müller T; Lubnow M; Luchner A; Lunz D; Riegger GA; Schmid C; Hengstenberg C; Hilker M
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E542-51. PubMed ID: 23554044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of aortic valve calcification on the outcome of transcatheter aortic valve implantation: results from the prospective multicenter German TAVI registry.
    Staubach S; Franke J; Gerckens U; Schuler G; Zahn R; Eggebrecht H; Hambrecht R; Sack S; Richardt G; Horack M; Senges J; Steinberg DH; Ledwoch J; Fichtlscherer S; Doss M; Wunderlich N; Sievert H;
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):348-55. PubMed ID: 22566406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of echocardiography in percutaneous aortic valve implantation.
    Moss RR; Ivens E; Pasupati S; Humphries K; Thompson CR; Munt B; Sinhal A; Webb JG
    JACC Cardiovasc Imaging; 2008 Jan; 1(1):15-24. PubMed ID: 19356400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility and accuracy of 3DTEE versus CT for the evaluation of aortic valve annulus to left main ostium distance before transcatheter aortic valve implantation.
    Tamborini G; Fusini L; Gripari P; Muratori M; Cefalù C; Maffessanti F; Alamanni F; Bartorelli A; Pontone G; Andreini D; Bertella E; Fiorentini C; Pepi M
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):579-88. PubMed ID: 22698526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system.
    Binder RK; Schäfer U; Kuck KH; Wood DA; Moss R; Leipsic J; Toggweiler S; Freeman M; Ostry AJ; Frerker C; Willson AB; Webb JG
    JACC Cardiovasc Interv; 2013 Mar; 6(3):301-7. PubMed ID: 23517843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Compassionate use of the self-expandable medtronic CoreValve prosthesis for the treatment of pure aortic regurgitation in a patient at prohibitive risk for surgical valve replacement.
    Hildebrandt HA; Erbel R; Kahlert P
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E939-43. PubMed ID: 23197445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-prosthesis mismatch after transapical aortic valve implantation: incidence and impact on survival.
    Kukucka M; Pasic M; Dreysse S; Mladenow A; Habazettl H; Hetzer R; Unbehaun A
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):391-7. PubMed ID: 22329976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful treatment of pure aortic insufficiency with transapical implantation of the JenaValve.
    Bleiziffer S; Mazzitelli D; Nöbauer C; Ried T; Lange R
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):428-30. PubMed ID: 23344750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies.
    Dvir D; Barbash IM; Ben-Dor I; Torguson R; Badr S; Minha S; Pendyala LK; Loh JP; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2013; 14(3):174-81. PubMed ID: 23773501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, outcome and correlates of residual paravalvular aortic regurgitation after transcatheter aortic valve implantation and importance of haemodynamic assessment.
    Patsalis PC; Konorza TF; Al-Rashid F; Plicht B; Riebisch M; Wendt D; Thielmann M; Jakob H; Eggebrecht H; Heusch G; Erbel R; Kahlert P
    EuroIntervention; 2013 Apr; 8(12):1398-406. PubMed ID: 23256946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of TEE as the primary imaging technique to guide transcatheter transapical aortic valve implantation.
    Bagur R; Rodés-Cabau J; Doyle D; De Larochellière R; Villeneuve J; Lemieux J; Bergeron S; Côté M; Bertrand OF; Pibarot P; Dumont E
    JACC Cardiovasc Imaging; 2011 Feb; 4(2):115-24. PubMed ID: 21329894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staged total percutaneous treatment of aortic valve pathology and mitral regurgitation: institutional experience.
    Kische S; D'Ancona G; Paranskaya L; Schubert J; Arsoy N; Hauenstein KH; Alozie A; Jovanovich B; Nienaber C; Ince H
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E552-63. PubMed ID: 23359543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option".
    Pesarini G; Bedogni F; Ribichini F
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):836-40. PubMed ID: 24038951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transapical aortic valve implantation in patients with previous cardiac surgery.
    Papadopoulos N; Ilioska P; Fichtlscherer S; Lehmann R; Beiras Fernandez A; Moritz A; Doss M; Zierer A
    Ann Thorac Surg; 2014 Jan; 97(1):37-42. PubMed ID: 24075497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of significant paravalvular regurgitation after transcatheter aortic valve: implantation impact of device and annulus discongruence.
    Détaint D; Lepage L; Himbert D; Brochet E; Messika-Zeitoun D; Iung B; Vahanian A
    JACC Cardiovasc Interv; 2009 Sep; 2(9):821-7. PubMed ID: 19778769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.